These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7852381)
41. Mutational analysis of the NH2-terminal glycosylation sites of the insulin receptor alpha-subunit. Caro LH; Ohali A; Gorden P; Collier E Diabetes; 1994 Feb; 43(2):240-6. PubMed ID: 8288048 [TBL] [Abstract][Full Text] [Related]
42. Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild type insulin-like growth factor 1 or insulin receptors. Langlois WJ; Sasaoka T; Yip CC; Olefsky JM Endocrinology; 1995 May; 136(5):1978-86. PubMed ID: 7720646 [TBL] [Abstract][Full Text] [Related]
43. Identification and characterization of the ligand-binding domain of insulin receptor by use of an anti-peptide antiserum against amino acid sequence 241-251 of the alpha subunit. Yip CC; Grunfeld C; Goldfine ID Biochemistry; 1991 Jan; 30(3):695-701. PubMed ID: 1988056 [TBL] [Abstract][Full Text] [Related]
44. Intra-A chain disulfide bond (A6-11) of insulin is essential for displaying its activity. Dai Y; Tang JG Biochem Mol Biol Int; 1994 Aug; 33(6):1049-53. PubMed ID: 7804129 [TBL] [Abstract][Full Text] [Related]
45. Mutagenesis of the ligand binding domain of the human retinoic acid receptor alpha identifies critical residues for 9-cis-retinoic acid binding. Tate BF; Grippo JF J Biol Chem; 1995 Sep; 270(35):20258-63. PubMed ID: 7657595 [TBL] [Abstract][Full Text] [Related]
46. Analysis of antibody A6 binding to the extracellular interferon gamma receptor alpha-chain by alanine-scanning mutagenesis and random mutagenesis with phage display. Lang S; Xu J; Stuart F; Thomas RM; Vrijbloed JW; Robinson JA Biochemistry; 2000 Dec; 39(51):15674-85. PubMed ID: 11123892 [TBL] [Abstract][Full Text] [Related]
47. Structural characterization of a homophilic binding site in the neural cell adhesion molecule. Rao Y; Wu XF; Yip P; Gariepy J; Siu CH J Biol Chem; 1993 Sep; 268(27):20630-8. PubMed ID: 8376414 [TBL] [Abstract][Full Text] [Related]
48. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor. Chanda PK; Minchin MC; Davis AR; Greenberg L; Reilly Y; McGregor WH; Bhat R; Lubeck MD; Mizutani S; Hung PP Mol Pharmacol; 1993 Apr; 43(4):516-20. PubMed ID: 8474430 [TBL] [Abstract][Full Text] [Related]
49. Mutagenesis of Phe381 and Phe382 in the extracellular domain of the insulin receptor: effects on receptor biosynthesis, processing, and ligand-dependent internalization. Accili D; Mosthaf L; Levy-Toledano R; Ullrich A; Taylor SI FEBS Lett; 1994 Mar; 341(1):104-8. PubMed ID: 8137907 [TBL] [Abstract][Full Text] [Related]
50. Site-directed mutagenesis of cysteinyl and serine residues of human thromboxane A2 receptor in insect cells. Chiang N; Kan WM; Tai HH Arch Biochem Biophys; 1996 Oct; 334(1):9-17. PubMed ID: 8837733 [TBL] [Abstract][Full Text] [Related]
51. Mutagenic structure/function analysis of the cytoplasmic cysteines of the insulin receptor. Macaulay SL; Polites M; Frenkel MJ; Hewish DR; Ward CW Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):811-20. PubMed ID: 7702578 [TBL] [Abstract][Full Text] [Related]
52. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. De Fea K; Roth RA Biochemistry; 1997 Oct; 36(42):12939-47. PubMed ID: 9335553 [TBL] [Abstract][Full Text] [Related]
53. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding. Mery L; Boulay F J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386 [TBL] [Abstract][Full Text] [Related]
54. The quinone-binding site in succinate-ubiquinone reductase from Escherichia coli. Quinone-binding domain and amino acid residues involved in quinone binding. Yang X; Yu L; He D; Yu CA J Biol Chem; 1998 Nov; 273(48):31916-23. PubMed ID: 9822661 [TBL] [Abstract][Full Text] [Related]
55. Direct determination of the insulin-insulin receptor interface using transferred cross-saturation experiments. Nakamura T; Takahashi H; Takahashi M; Shimba N; Suzuki E; Shimada I J Med Chem; 2010 Mar; 53(5):1917-22. PubMed ID: 20158183 [TBL] [Abstract][Full Text] [Related]
56. The functions of the human insulin receptor are affected in different ways by mutation of each of the four N-glycosylation sites in the beta subunit. Leconte I; Carpentier JL; Clauser E J Biol Chem; 1994 Jul; 269(27):18062-71. PubMed ID: 8027066 [TBL] [Abstract][Full Text] [Related]
57. Mapping of the insulin-like growth factor II binding site of the Type I insulin-like growth factor receptor by alanine scanning mutagenesis. Sørensen H; Whittaker L; Hinrichsen J; Groth A; Whittaker J FEBS Lett; 2004 May; 565(1-3):19-22. PubMed ID: 15135045 [TBL] [Abstract][Full Text] [Related]
58. A novel insulin receptor substrate protein, xIRS-u, potentiates insulin signaling: functional importance of its pleckstrin homology domain. Ohan N; Bayaa M; Kumar P; Zhu L; Liu XJ Mol Endocrinol; 1998 Aug; 12(8):1086-98. PubMed ID: 9717835 [TBL] [Abstract][Full Text] [Related]
59. Defining the LGR8 residues involved in binding insulin-like peptide 3. Scott DJ; Wilkinson TN; Zhang S; Ferraro T; Wade JD; Tregear GW; Bathgate RA Mol Endocrinol; 2007 Jul; 21(7):1699-712. PubMed ID: 17473281 [TBL] [Abstract][Full Text] [Related]
60. The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site. Kjeldsen T; Andersen AS; Wiberg FC; Rasmussen JS; Schäffer L; Balschmidt P; Møller KB; Møller NP Proc Natl Acad Sci U S A; 1991 May; 88(10):4404-8. PubMed ID: 1852007 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]